Product
Captopril
Aliases
Captopril 25Mg Tab, Captopril Tablets
Name
Captopril
INN Name
Captopril
FDA Approved
Yes
11 clinical trials
1 organization
10 indications
1 document
Indication
Healthy Control ParticipantsIndication
HypertensionIndication
Type 1 DiabetesIndication
Mitral Valve ProlapseIndication
Congenital Heart FailureIndication
Primary Name: OsteomyelofibrosisIndication
Myeloproliferative NeoplasmIndication
Hypertension,EssentialIndication
Hormone Replacement TherapyIndication
Drug EffectClinical trial
An Open-label, Randomized Three Period, Three Sequence, Partially Replicated Crossover Bioequivalence Study of Two Oral Formulations of Captopril 50 mg Film Coated Tablets in Healthy Adult Participants Under Fasting ConditionsStatus: Withdrawn, Estimated PCD: 2022-03-25
Clinical trial
Efficacy and Safety of Roselle in Patients With Grade 1 Essential Hypertension: A Phase III, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-04-01
Clinical trial
Oxidative Stress in Children and Adolescents With Diabetic Nephropathy and the Role of Adjuvant Alpha-lipoic Acid as an AntioxidantStatus: Recruiting, Estimated PCD: 2024-01-31
Clinical trial
A Prospective Controlled Study for the Treatment Effect of Different Intervention Strategies for Pediatric Mitral Regurgitation--A Multicenter Prospective Cohort Study of Innovative Drug Therapy for Pediatric Mitral RegurgitationStatus: Recruiting, Estimated PCD: 2024-08-09
Clinical trial
A Comprehensive Research of Pediatric Heart Failure--A Prospective Cohort Study of Drug Therapy for Pediatric Heart FailureStatus: Recruiting, Estimated PCD: 2024-06-22
Clinical trial
A Prospective Controlled Study for the Treatment Effect of Different Intervention Strategies for Pediatric Mitral Regurgitation--A Multicenter Prospective Cohort Study of Innovative Drug Therapy in Improving Left Ventricular Function After Mitral RepairStatus: Recruiting, Estimated PCD: 2024-10-15
Clinical trial
Phase I/II Prospective Trial Investigating the Safety and Efficacy of Captopril Use on the Degree of Marrow Fibrosis in Patients With Primary or Secondary Bone Marrow Fibrosis/Myeloproliferative NeoplasmsStatus: Withdrawn, Estimated PCD: 2024-10-01
Clinical trial
An Open-label, Fixed-sequence, 3-period Crossover Exploratory Study to Investigate the Effect of Urine Acid-base Disequilibrium on the Pharmacokinetics of Captopril in Healthy Male VolunteersStatus: Completed, Estimated PCD: 2024-03-27
Clinical trial
Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvascular Function and Vessel Remodeling in Hypertensive HumansStatus: Terminated, Estimated PCD: 2022-08-31
Clinical trial
Hormone Therapy and Angiotensin-Dependent Arterial and RenalStatus: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
Intermediate Term Effect of Captopril on Left Ventricle Global Longitudinal Strain in Patients With Duchenne MyodystrophyStatus: Recruiting, Estimated PCD: 2024-06-30
Document
DailyMed Label: CaptoprilOrganization
State of Florida DOH Central Pharmacy